Hypertrophic Cardiomyopathy Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
The purpose of this study is to assess the safety, tolerability, and potential efficacy of IMB-1018972 in patients with non-obstructive HCM.
Diagnosis of Hypertrophic Cardiomyopathy consistent with current US and European guidelines
Ability to perform an upright treadmill cardiopulmonary exercise test
Agreement to abide by contraceptive requirements
Clinically significant concurrent condition which could prevent the patient from performing any of the protocol-specified assessments, represent a safety concern if the patient participates in the trial or could confound trial assessments of safety or tolerability
Women who are pregnant, planning to become pregnant or lactating
Participation in another clinical study involving a test product or invasive medical device within 28 days (or within 5 elimination half-lives of the respective test product, whichever is longer), prior to first dosing
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 13 Locations for this study
La Jolla California, 92093, United States
Los Angeles California, 90048, United States
San Francisco California, 94143, United States
Chicago Illinois, 60611, United States
Boston Massachusetts, 02111, United States
Burlington Massachusetts, 01805, United States
Saint Louis Missouri, 63110, United States
Morristown New Jersey, 07960, United States
New York New York, 10016, United States
Charlotte North Carolina, 28203, United States
Portland Oregon, 97239, United States
Houston Texas, 77030, United States
Salt Lake City Utah, 84112, United States
Oxford , , United Kingdom
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.